Praxis Precision Medicines, Inc. PRAX Free cash flow yield
Free cash flow yield at other companies
Other financials
Where this comes from
Calculated from Praxis Precision Medicines, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Praxis Precision Medicines, Inc.'s free cash flow yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Praxis Precision Medicines, Inc.'s free cash flow yield?
- Praxis Precision Medicines, Inc. (PRAX) reported free cash flow yield of -3.1% in Q1 2026.
- How has Praxis Precision Medicines, Inc.'s free cash flow yield changed year-over-year?
- Praxis Precision Medicines, Inc.'s free cash flow yield increased by 85.3% year-over-year, from -21.5% to -3.1%.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s free cash flow yield?
- Over 5 years (2020 to 2025), Praxis Precision Medicines, Inc.'s free cash flow yield has grown at a 9.7% compound annual growth rate (CAGR), from -2.1% to -3.4%.
- What does free cash flow yield mean?
- Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.